Advertisement

Research Article Free access | 10.1172/JCI107233

Triketocholanoic (Dehydrocholic) Acid. HEPATIC METABOLISM AND EFFECT ON BILE FLOW AND BILIARY LIPID SECRETION IN MAN

Roger D. Soloway, Alan F. Hofmann, Paul J. Thomas, Leslie J. Schoenfield, and Peter D. Klein

Gastroenterology Unit, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55901

Argonne National Laboratories, Argonne, Illinois 60439

Find articles by Soloway, R. in: PubMed | Google Scholar

Gastroenterology Unit, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55901

Argonne National Laboratories, Argonne, Illinois 60439

Find articles by Hofmann, A. in: PubMed | Google Scholar

Gastroenterology Unit, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55901

Argonne National Laboratories, Argonne, Illinois 60439

Find articles by Thomas, P. in: PubMed | Google Scholar

Gastroenterology Unit, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55901

Argonne National Laboratories, Argonne, Illinois 60439

Find articles by Schoenfield, L. in: PubMed | Google Scholar

Gastroenterology Unit, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55901

Argonne National Laboratories, Argonne, Illinois 60439

Find articles by Klein, P. in: PubMed | Google Scholar

Published March 1, 1973 - More info

Published in Volume 52, Issue 3 on March 1, 1973
J Clin Invest. 1973;52(3):715–724. https://doi.org/10.1172/JCI107233.
© 1973 The American Society for Clinical Investigation
Published March 1, 1973 - Version history
View PDF
Abstract

[24-14C]Dehydrocholic acid (triketo-5-β-cholanoic acid) was synthesized from [24-14C]cholic acid, mixed with 200 mg of carrier, and administered intravenously to two patients with indwelling T tubes designed to permit bile sampling without interruption of the enterohepatic circulation. More than 80% of infused radioactivity was excreted rapidly in bile as glycine- and taurine-conjugated bile acids. Radioactive products were identified, after deconjugation, as partially or completely reduced derivatives of dehydrocholic acid. By mass spectrometry, as well as chromatography, the major metabolite (about 70%) was a dihydroxy monoketo bile acid (3α,7α-dihydroxy-12-keto-5β-cholanoic acid); a second metabolite (about 20%) was a monohydroxy diketo acid (3α-hydroxy-7,12-di-keto-5β-cholanoic acid); and about 10% of radioactivity was present as cholic acid. Reduction appeared to have been sequential (3 position, then 7 position, and then 12 position) and stereospecific (only α epimers were recovered).

Bile flow, expressed as the ratio of bile flow to bile acid excretion, was increased after dehydrocholic acid administration. It was speculated that the hydroxy keto metabolites are hydrocholeretics. The proportion of cholesterol to lecithin and bile acids did not change significantly after dehydrocholic acid administration. In vitro studies showed that the hydroxy keto metabolites dispersed lecithin poorly compared to cholate; however, mixtures of cholate and either metabolite had dispersant properties similar to those of cholate alone, provided the ratio of metabolite to cholate remained below a value characteristic for each metabolite. These experiments disclose a new metabolic pathway in man, provide further insight into the hydrocholeresis induced by keto bile acids, and indicate the striking change in pharmacologic and physical properties caused by replacement of hydroxyl by a keto substituent in the bile acid molecule.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (March 1, 1973): No description
Advertisement
Advertisement